Multiplexed cell analysis on CellCards for drug discovery

Ilya Ravkin; Vladimir Temov; Aaron D. Nelson; Michael A. Zarowitz; Matthew Hoopes; Yuli Verhovsky; Gregory Ascue; Simon Goldbard; Oren Beske; Bhagyashree Bhagwat; Holly Marciniak

doi:10.1117/12.528081

22 June 2004 Multiplexed cell analysis on CellCards for drug discovery

Ilya Ravkin, Vladimir Temov, Aaron D. Nelson, Michael A. Zarowitz, Matthew Hoopes, Yuli Verhovsky, Gregory Ascue, Simon Goldbard, Oren Beske, Bhagyashree Bhagwat, Holly Marciniak

Author Affiliations +

Proceedings Volume 5328, Microarrays and Combinatorial Techniques: Design, Fabrication, and Analysis II; (2004) https://doi.org/10.1117/12.528081
Event: Biomedical Optics 2004, 2004, San Jose, CA, United States

Abstract

The desire to obtain more biologically relevant data is expanding the use of cell-based assays in drug discovery. These assays are performed and analyzed in ever more sophisticated ways (e.g. high content screening) that allow the collection of multiparametric information about cells affected by the screened compounds. The driver for these developments is the desire to increase data quality and density and reduce the use of valuable reagents and time. Here we describe an approach that adds a new dimension to the data quality/quantity mix by simultaneously analyzing several cell types in the same microplate well. The system is based on the use of encoded carriers (CellCards) that permit the reading and analysis of cellular responses, and at the same time allow decoding and the attribution of these responses to the appropriate cell line. CellCards are rectangular particles with an expandable color barcode and a transparent section upon which cells can be grown and imaged for cellular readout. Before performing the assay, each cell line is grown on a different class of CellCards. CellCards, with attached cells, are mixed and dispensed into a microtiter plate where the assay is performed. Next the plates are imaged, decoded and the cells associated with each CellCard class are analyzed. Multiplexing cell lines allows assay controls and data normalization within each well, reducing well-to-well variability. It also allows the simultaneous interrogation of multiple targets and thus concurrent potency and selectivity screening. This may significantly reduce the time required to take a compound from primary screening into the clinic.

Citation Download Citation

Ilya Ravkin, Vladimir Temov, Aaron D. Nelson, Michael A. Zarowitz, Matthew Hoopes, Yuli Verhovsky, Gregory Ascue, Simon Goldbard, Oren Beske, Bhagyashree Bhagwat, and Holly Marciniak "Multiplexed cell analysis on CellCards for drug discovery", Proc. SPIE 5328, Microarrays and Combinatorial Techniques: Design, Fabrication, and Analysis II, (22 June 2004); https://doi.org/10.1117/12.528081

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available